Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug.
Cancer
Encapsulation
Methionine
Methionine-γ-lyase
Pyridoxine
Journal
Medical & biological engineering & computing
ISSN: 1741-0444
Titre abrégé: Med Biol Eng Comput
Pays: United States
ID NLM: 7704869
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
28
12
2020
accepted:
17
01
2023
medline:
20
6
2023
pubmed:
8
3
2023
entrez:
7
3
2023
Statut:
ppublish
Résumé
A new therapeutic approach against cancer is developed by the firm Erytech. This approach is based on starved cancer cells of an amino acid essential to their growth (the L-methionine). The depletion of plasma methionine level can be induced by an enzyme, the methionine-γ-lyase. The new therapeutic formulation is a suspension of erythrocytes encapsulating the activated enzyme. Our work reproduces a preclinical trial of a new anti-cancer drug with a mathematical model and numerical simulations in order to replace animal experiments and to have a deeper insight on the underlying processes. With a combination of a pharmacokinetic/pharmacodynamic model for the enzyme, substrate, and co-factor with a hybrid model for tumor, we develop a "global model" that can be calibrated to simulate different human cancer cell lines. The hybrid model includes a system of ordinary differential equations for the intracellular concentrations, partial differential equations for the concentrations of nutrients and drugs in the extracellular matrix, and individual based model for cancer cells. This model describes cell motion, division, differentiation, and death determined by the intracellular concentrations. The models are developed on the basis of experiments in mice carried out by Erytech. Parameters of the pharmacokinetics model were determined by fitting a part of experimental data on the concentration of methionine in blood. Remaining experimental protocols effectuated by Erytech were used to validate the model. The validated PK model allowed the investigation of pharmacodynamics of cell populations. Numerical simulations with the global model show cell synchronization and proliferation arrest due to treatment similar to the available experiments. Thus, computer modeling confirms a possible effect of treatment based on the decrease of methionine concentration. The main goal of the study is the development of an integrated pharmacokinetic/pharmacodynamic model for encapsulated methioninase and of a mathematical model of tumor growth/regression in order to determine the kinetics of L-methionine depletion after co-administration of Erymet product and Pyridoxine.
Identifiants
pubmed: 36882575
doi: 10.1007/s11517-023-02786-2
pii: 10.1007/s11517-023-02786-2
doi:
Substances chimiques
Methionine
AE28F7PNPL
Antineoplastic Agents
0
Racemethionine
73JWT2K6T3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1697-1722Informations de copyright
© 2023. International Federation for Medical and Biological Engineering.
Références
Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM (1983) The metabolic defect of methionine occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117(2)
Judde JG, Frost P (1988) Patterns of methionine auxotrophy in normal and neoplastic cells: the methionine independence of lymphocyte mitogenesis and low frequency of the methionine-dependent phenotype in human. Tumors Cancer Res 48:6775–6779
pubmed: 3180086
Kokkinakis DM, Schold, SC Jr, Hori H, Nobori T (1997) Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice. Nutr Cancer 29(3):195–204. https://doi.org/10.1080/01635589709514624
doi: 10.1080/01635589709514624
pubmed: 9457739
Hoshiya Y, Guo H, Kubota T, Inada T, Asanuma F, Yamada Y, Koh J, Kitajima M, Hoffman RM (1995) Human tumors are methionine-dependent in vivo. Anticancer Res 15:717–718
pubmed: 7645948
Pavillard V, Drbal AAA, Swaine DJ, Phillips RM, Double JA, Nicolaou A (2004) Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation. Biochem Pharmacol 67:1587–1599
doi: 10.1016/j.bcp.2004.01.006
pubmed: 15041476
Tan Y, Zavala, J Sr, Xu M, Zavala, J Jr, Hoffman RM (1996) Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients. Anticancer Res 16(6C):3937–42
pubmed: 9042316
Tan Y, Zavala, J Sr, Han Q, Xu M, Sun X, Tan X, Magana R, Geller J, Hoffman RM (1997) Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients. Anticancer Res 17(5B):3857–60
pubmed: 9427792
Gilbert H (1999) Basic concepts in Biochemistry. ISBN: 0071356576
Gérard C, Goldbeter A (2015) Dynamics of the mammalian cell cycle in physiological and pathological conditions. WIREs Syst Biol Med. https://doi.org/10.1002/wsbm.1325
Hens JR, Sinha I, Perodin F, Cooper T, Sinha R, Plummer J, Perrone CE, Orentreich D (2016) Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice. Hens othersBMC Cancer 16:349. https://doi.org/10.1186/s12885-016-2367-1
doi: 10.1186/s12885-016-2367-1
pubmed: 27255182
Dua P, Hawkins E, van der Graaf PH (2015) A tutorial on target-mediated drug disposition (TMDD) models. CPTPharmacometricsSyst Pharmacol 4:324–33
Fischer S, Kurbatova P, Bessonov N, Gandrillon O, Volpert V, Crauste F (2012) Modelling erythroblastic islands: using a hybrid model to assess the function of central macrophage. J Theo Biol 298:92–106
doi: 10.1016/j.jtbi.2012.01.002
Deutsch A (2007) Lattice-gas cellular automaton modeling of developing cell systems. Single-Cell-Based Models in Biology and Medicine, Mathematics and Biosciences in Interaction, 29–51
Dallon JC (2007) Models with lattice-free center-based cells interacting with continuum environment variables. Single Cell Based Models in Biology and Medicine, Mathematics and Biosciences in Interaction, III, 197–219
Eymard N, Bessonov N, Gandrillon O, Koury MJ, Volpert V (2015) The role of spatial organization of cells in erythropoiesis. J Math Biol 70(1):71–97
doi: 10.1007/s00285-014-0758-y
pubmed: 24496930
Alarcón T, Byrneb HM, Mainia PKA (2003) cellular automaton model for tumour growth in inhomogeneous environment. J Theor Biol 225:257–274
doi: 10.1016/S0022-5193(03)00244-3
pubmed: 14575659
Anderson ARA, Chaplain MAJ (1998) Continuous discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol 60(5):857–99
doi: 10.1006/bulm.1998.0042
pubmed: 9739618
Anderson ARA, Chaplain MAJ, Rejniak KA (2007) The cellular Potts model and its variants. Single-Cell-Based Models in Biology and Medicine
Kurbatova P, Eymard N, Volpert V (2013) Hybrid model of erythropoiesis. Acta Biotheor 61(3):305–315
doi: 10.1007/s10441-013-9188-2
pubmed: 23904072
Eymard N, Kurbatova P (2015) Hybrid models in hematopoiesis. Math Model Nat Phenom 10(1):48–63
doi: 10.1051/mmnp/201510103
Bessonov N, Crauste F, Fischer S, Kurbatova P, Volpert V (2011) Application of hybrid models to blood cell production in the bone marrow. Math Model Nat Phenom 6(7):2–12
doi: 10.1051/mmnp/20116701
Bessonov N, Kurbatova P, Volpert V (2010) Particle dynamics modelling of cell populations. Math Model Nat Phenom 5(7):42–47. JANO9 The 9th International Conference on Numerical Analysis and Optimization
doi: 10.1051/mmnp/20105707
Kurbatova P, Bernard S, Bessonov N, Crauste F, Demin I, Dumontet C, Fischer S, Volpert V (2011) Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside. SIAM J App Math 71(6):2246–2268
doi: 10.1137/100815517
Sun X, Yang Z, Li S, Tan Y, Zhang N, Wang X, Yagi S, Yoshioka T, Takimoto A, Mitsushima K, Suginaka A, Frenkel EP, Hoffman RM (2003) In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5-phosphate supplementation. Cancer Res 63:8377–8383
pubmed: 14678999
Yang Z, Wang J, Yoshioka T, Li B, Lu Q, Li S, Sun X, Tan Y, Yagi S, Frenkel EP, Robert M, Hoffman RM (2004) Pharmacokinetics methionine depletion, and antigenicity of recombinant methioninase in primates. Clin Cancer Res 10:2131–2138
doi: 10.1158/1078-0432.CCR-03-0068
pubmed: 15041734
Hoffman RM, Erbe RW (1976) High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci USA 73:1523–1527
doi: 10.1073/pnas.73.5.1523
pubmed: 179090
pmcid: 430329
Blom HJ, Smulders Y (2011) Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis 34:75–81. https://doi.org/10.1007/s10545-010-9177-4
doi: 10.1007/s10545-010-9177-4
pubmed: 20814827
Medina MA, Urdiales JL, Amores-Sanchez MI (2001) Roles of homocysteine in cell metabolism Old and new functions. Eur J Biochem 268:3871–3882
doi: 10.1046/j.1432-1327.2001.02278.x
pubmed: 11453979
Stipanuk MH, Ueki I (2011) Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis 34(1):17–32. https://doi.org/10.1007/s10545-009-9006-9
doi: 10.1007/s10545-009-9006-9
pubmed: 20162368
Banerjee RV, Matthews RG (1990) Cobalamin-dependent methionine synthase. FASEB J 4 (5):1450–9
doi: 10.1096/fasebj.4.5.2407589
pubmed: 2407589
Poomipark N, Flatley JE, Hill MH, Mangnall B, Azar E, Grabowski P, Powers HJ (2016) Methyl donor status influences DNMT expression and Global DNA methylation in cervical cancer cells. Asian Pac J Cancer Prev :17
Hu J, Cheung N-KV (2009) Methionine depletion with recombinant methioninase: In vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs. Int J Cancer 124(7):1700–1706. https://doi.org/10.1002/ijc.24104
doi: 10.1002/ijc.24104
pubmed: 19089915
pmcid: 2700741
Hoffman RM (2017) Is DNA methylation the new guardian of the genome? Mol Cytogenet 10:11. https://doi.org/10.1186/s13039-017-0314-8 . eCollection 2017
doi: 10.1186/s13039-017-0314-8
pubmed: 28396696
pmcid: 5381125
Murakami T, Li S, Han Q, Tan Y, Kiyuna T, Igarashi K, Kawaguchi K, Hwang HK, Miyake K, Singh AS, Nelson SD, Dry SM, Li Y, Hiroshima Y, Lwin TM, DeLong JC, Chishima T, Tanaka K, Bouvet M, Endo I, Eilber FC, Hoffman RM (2017) Recombinant methioninase effectively targets a Ewing’s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. https://doi.org/10.18632/oncotarget.15823 .
Lu S, Epner DE (2000) Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 38(1):123–130
doi: 10.1207/S15327914NC381_17
pubmed: 11341037
Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P (2003) Methionine dependency and cancer treatment. Cancer Treat Rev 29:489–499. https://doi.org/10.1016/S0305-7372(03)00118-X
doi: 10.1016/S0305-7372(03)00118-X
pubmed: 14585259
El-Sayed ASA, Ruff LE, Ghany SEA, Ali GS, Esener S (2016) Molecular and spectroscopic characterization of aspergillus flavipes and pseudomonas putida L-Methionine γ-Lyase in Vitro. Appl Biochem Biotechnol https://doi.org/10.1007/s12010-016-2299-x
Özkan YE, Yardim-Akaydin S, Firat H, Çalişkan-Can E, Ardiç S, Şimşek B (2007) Usefulness of homocysteine as a cancer marker: Total thiol compounds and folate levels in untreated lung cancer patients. Anticancer Res 27:1185–1190
pubmed: 17465261
Fischer S, Kurbatova P, Bessonov N, Gandrillon O, Volpert V, Crauste F (2012) Modelling erythroblastic islands: using a hybrid model to assess the function of central macrophage. Theo Biol 298:92–106
doi: 10.1016/j.jtbi.2012.01.002
Bessonov N, Demin I, Pujo-Menjouet L, Volpert V (2009) A multi-agent model describing self-renewal of differentiation effects on the blood cell population. Math Comput Model :2116–2127
Bessonov N, Crauste F, Fischer S, Kurbatova P, Volpert V (2011) Application of hybrid models to blood cell production in the bone marrow. Math Model Nat Phenom (7):2–12
Kurbatova P, Eymard N, Volpert V (2013) Hybrid model of erythropoiesis. Acta Biotheor 61(3):305–315
doi: 10.1007/s10441-013-9188-2
pubmed: 23904072
Eymard N, Kurbatova P (2015) Hybrid models in hematopoiesis and in Megakaryopoiesis. Math Model Nat Phenom 10(1):48–63
doi: 10.1051/mmnp/201510103
Eymard N, Bessonov N, Gandrillon O, Koury MJ, Volpert V (2015) The role of spatial organization of cells in erythropoiesis. J Math Biol 70(1):71–97
doi: 10.1007/s00285-014-0758-y
pubmed: 24496930
(2011) Hybrid modelling of erythropoiesis and blood disorders. Polina Kurbatova Thesis
Dayneka NL, Garg V, Jusko WJ (1993) Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21(4):457–478
doi: 10.1007/BF01061691
pubmed: 8133465
pmcid: 4207304
Goutelle S, Maurin M, Rougier F, Barbaut X, Bourguignon L, Ducher M, Maire P (2008) The Hill equation: a review of its capabilities in pharmacological modelling. Soc Française Pharmacol de Thérapeutique Fundam Clin Pharmacol 22:633–648
doi: 10.1111/j.1472-8206.2008.00633.x
Bellu G, Saccomani MP, Audoly S, D’Angio L (2007) DAISY: A new software tool to test global identifiability of biological and physiological systems. Comput Methods Programs Biomed 88(1):52–61
doi: 10.1016/j.cmpb.2007.07.002
pubmed: 17707944
pmcid: 2888537
Gross E, Meshkat N, Shiu A Identifiability of linear compartmental models: The singular locus. Available online 14 October 2021, Version of Record 15 November 2021
Godfrey KR, Jones RP, Brown RF The identifiability of linear models
Model Identifiability. Paola Lecca, Chapter of the book “Identifiability and Regression Analysis of Biological Systems Models” First Online: 06 March 2020